Found 0 matching trials
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation PHASE1 This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Show More Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Learn More & Join Trial
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma PHASE2 RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma NA This clinical trial studies peripheral blood hemapoietic stem cell mobiliza...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Allogeneic Cell Therapy for Adults With Hematologic Malignancies PHASE2 This is a research study involving the treatment of leukemia or lymphoma (l...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia PHASE1 Phase I trial to study the effectiveness of augmerosen plus fludarabine and...
Show More Location
Arthur G. James Cancer Hospital - Ohio State University
Learn More & Join Trial
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia PHASE1 Background:
Sickle cell disease (SCD) is an inherited disorder of the bloo...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease PHASE1 Background:
Peripheral blood stem cell transplantation procedures are used...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases PHASE2 RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L PHASE2 The purpose of this study is to compare the effects, good and bad, of two w...
Show More Location
Memoral Sloan Kettering Cancer Center
Learn More & Join Trial
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma PHASE2 Background:
The mainstay of therapy for newly diagnosed multiple myeloma p...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial